December 1, 2022
Jonathan Frostick’s first resolution after suffering a heart attack in April was to cut down on video conferencing at work. “I’m not spending all day on zoom (sic) anymore,” the London, U.K.-based program manager financial services firm HSBC, wrote on LinkedIn last month.“I’m restructuring my approach to work,” Frostick continued. “I’m really not going to be putting up with any s#%t at work ever again — life literally is too short.”The vow struck a chord. The post has attracted more 295,000 likes and 15,000 comments so far, with readers sympathizing with Frostick and sharing readmore
The Canadian dollar has come a long way in the past year and its trajectory places it among the strongest currencies of 2021. It has been trading above 81 cents relative to the greenback for seven days in a row, and currency analysts say it could climb further in coming months.The loonie had plunged to 70 cents US at the onset of the pandemic, when fearful investors piled into the perceived safety of the greenback. And commodity prices collapsed. But things are different now.As the uneven global recovery begins — with Asian economies at the forefront and China leading the charge — demand readmore
Illustration: Alex Nabaumreadmore
AstraZeneca said its COVID-19 vaccine sales were $275 million in the first-quarter and it is on track to deliver 200 million doses a month from April, as better-than-expected results and a second-half growth forecast boosted its shares. Chief Executive Pascal Soriot again defended the vaccine rollout on Friday, saying that Anglo-Swedish drugmaker had not overpromised on its ability to supply shots, as he defended big cuts in deliveries that prompted a European Union lawsuit.READ MORE: ‘Demand is outstripping the supply’ — Is Canada running out of AstraZeneca COVID-19 vaccines?AstraZeneca, which has said it will not make a profit from the shot readmore
